v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Mar. 31, 2026
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF RESERVED SHARES

 

      
Conversion of Series A-2 preferred stock   267,587 
Conversion of Series B preferred stock   2,709,261 
Exercise of stock warrants   1,226,595 
Total   4,203,443 
SCHEDULE OF OUTSTANDING PREFERRED STOCK

 

   Authorized Shares   Outstanding Shares   Conversion Price   Common Stock Equivalent 
Series A-2   7,000    601   $2.246    267,587 
Series B   500,000    6,085   $2.246    2,709,261 
Compensatory Warrant Activity [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF NON COMPENSATORY WARRANT ACTIVITY

The following table summarizes the equity classified compensatory warrant activity for the three months ended March 31, 2026:

 

    Common Stock 
    Shares    

Weighted–

Average
Exercise
Price

    Range of
Exercise Price
    Weighted–
Average
Remaining
Life (Years)
 
Total outstanding – December 31, 2025   160   $1,270.25    $1,270.25 — $1,270.25    0.81 
Exercised                
Expired   (53)            
Forfeited                
Total outstanding – March 31, 2026   107   $1,270.25    $1,270.25— $1,270.25    0.90 
Exercisable   107   $1,270.25    $1,270.25 — $1,270.25    0.90 
Non-Exercisable                
Non Compensatory Warrant Activity [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF NON COMPENSATORY WARRANT ACTIVITY

The following table summarizes the noncompensatory equity classified warrant activity for the three months ended March 31, 2026:

 

   Common Stock 
   Shares   Weighted–
Average
Exercise
Price
   Range of
Exercise Price
   Weighted–
Average
Remaining
Life (Years)
 
Total outstanding – December 31, 2025   1,159,270   $2.72    $2.47 — $6.50     4.64 
Granted                
Exercised                
Expired                
Forfeited                
Total outstanding – March 31, 2026   1,159,270   $2.72    $2.47 — $6.50     4.39 
Exercisable   1,159,270   $2.72    $2.47 — $6.50     4.39 
Non-Exercisable                

 

The following table summarizes the noncompensatory equity classified warrant activity for the three months ended March 31, 2025:

 

    Common Stock 
    Shares    Weighted–
Average
Exercise
Price
    Range of
Exercise Price
    Weighted–
Average
Remaining
Life (Years)
 
Total outstanding – December 31, 2024   72,004   $6.50    $6.50 — $6.50     3.99 
Granted                
Exercised                
Expired                
Forfeited                
Total outstanding – March 31, 2025   72,004   $6.50    $6.50 — $6.50     3.74 
Exercisable   72,004   $6.50    $6.50 — $6.50     3.74 
Non-Exercisable